Analytics

Field Force Effectiveness in Pharma: The Metrics, the Data and a Worked Diagnostic

Field force effectiveness in pharma, measured properly: the KPI chain from targeting to new prescriptions, a worked territory diagnostic and the data needed.

Nov 202610 min readAnalytics

The short answer

Field force effectiveness in pharma is the measure of whether your reps reach the right prescribers, often enough, with a message that lands, and whether prescribing changes as a result. It is tracked as a chain: target list quality, reach, frequency, call quality, channel coordination and then outcomes such as new-to-brand prescriptions, all compared with what the field force costs. When one link in that chain breaks, the fix is usually targeting or execution, not more reps.

Most companies already have the raw material: CRM calls, a target list, a territory alignment and prescription data. What they lack is those sources joined at prescriber level, with one set of definitions, refreshed every week. Without that, field force effectiveness turns into a monthly argument between brand, sales operations and the regions about whose numbers are right.

This guide sets out the metrics with formulas and data sources, a worked diagnostic for two territories, the data model underneath, build versus buy options for a company with 20 to 80 reps, and when field force analytics is not worth funding yet. It is written for commercial operations and sales leaders at small and mid-sized pharma and biotech companies.

Why the old activity metrics stopped working

45%of US HCPs accessible to biopharma reps, down from 60% eighteen months earlier (Veeva Pulse Field Trends Report, May 2024)
Halfof accessible HCPs restrict engagement to three or fewer companies (same report)
65%of HCP engagements not synchronised between sales and marketing (Veeva Pulse, November 2024)
30%more likely to prescribe when a rep meeting is followed by digital exposure within 10 days (same report)

What field force effectiveness in pharma actually measures

Calls per day was a reasonable proxy when most doctors saw most reps. With access at the levels Veeva reports, a rep can hit an activity target by calling on whoever will see them, and the brand gets nothing for it. The metrics that matter follow the path from plan to prescription:

MetricFormulaData sourceTrap to avoid
Call-on-target rateCalls to target-list HCPs / all callsCRM calls joined to the target listTarget lists that change mid-cycle without a dated history
ReachTargets with at least one call / targets on the listCRM calls, target listCounting the same doctor twice under two addresses
FrequencyCalls to reached targets / reached targets, by segmentCRM calls, segment flagsAveraging across segments hides under-called A targets
Plan attainmentActual calls / planned calls, by segmentCall plan, CRM callsPlans set from last year's habits rather than this year's targeting
Access rateTargets seen at least once in the period / targets attemptedCRM calls and attempts, no-see flagsReps not logging failed attempts, so access looks perfect
Channel coordinationShare of rep calls followed by an approved email, website visit or event within a set windowCRM, marketing automation, web analyticsDifferent HCP identifiers in each system
Outcome liftNew-to-brand prescriptions in called targets vs a matched, less-called groupPrescriber-level prescription dataCrediting reps for prescribers who were already growing
Cost per outcomeFully loaded territory cost / new patients or new-to-brand prescriptionsFinance, roster, prescription dataComparing territories with very different potential

Notice that only the last two say anything about results. The first six are diagnostics: they tell you where the chain broke so you know what to fix. For definitions of the prescription measures, see our explainer on NBRx vs NRx and new patient starts.

Worked example: two territories, same headcount, different results

The figures below are invented for illustration. Both territories have one rep, the same 120 A-segment targets and a plan of 16 calls a year to each A target, so 1,920 planned A calls.

MeasureNorthSouth
Total calls in the year1,6001,700
Calls to target-list HCPs1,040 (65%)1,445 (85%)
A targets reached102 of 120 (85%)110 of 120 (92%)
Calls to A targets7201,320
Frequency per reached A target7.112.0
A-segment plan attainment38% (720 of 1,920)69% (1,320 of 1,920)
New-to-brand prescriptions from A targets210300

What the activity report says. North made 1,600 calls against South's 1,700. On a calls-per-day scorecard the two reps look almost the same.

What the chain says. North spends 560 calls, 35 percent of its effort, on prescribers who are not on the target list, and its A targets get fewer than half the calls the plan asks for. South's lead is not effort; it is where the effort goes.

The fix. If North moved 360 of its off-list calls to the A targets it already reaches, A calls would rise from 720 to 1,080 and frequency from 7.1 to about 10.6, with no change in headcount. Whether that lifts new-to-brand prescriptions is then tested, not assumed: compare North's A targets with a matched group over the next two quarters.

What not to conclude. North may have more no-see A targets, a wider geography or an older target list. The diagnostic tells you which questions to ask the rep and manager; it does not replace the conversation. If access is the real barrier, the answer may be video, an inside sales team or medical engagement rather than more calls.

The data you need, and how it has to fit together

Field force effectiveness metrics are only as good as the joins underneath them. A workable model for a mid-sized company has five parts:

  • A prescriber master. One record per HCP keyed on NPI, with specialty, address and affiliations, matched across CRM, prescription data and marketing systems. Veeva OpenData and IQVIA OneKey are the main US reference sources; our comparison of Veeva OpenData vs IQVIA OneKey covers the choice.
  • A dated target list and segmentation. Which HCPs were targets, in which segment, from which date. Without effective dates, reach and frequency are calculated against today's list, not the one reps were working. Our guide to HCP segmentation in pharma covers how the segments are built.
  • A dated territory roster and alignment. Which rep covered which ZIP codes and accounts, including vacancies, so a vacant territory is not scored as a failing rep.
  • CRM activity. Calls, attempts, samples, emails and events from Veeva or Salesforce, loaded daily or weekly. Our Veeva CRM data integration work usually starts here.
  • Prescriber-level demand. Licensed prescription data at NPI level, with new-to-brand flags where your contract includes them, plus specialty pharmacy data for limited-distribution brands.

Build this once in a commercial data model and every downstream use reads from it: field scorecards, incentive compensation goals, sizing reviews and omnichannel analytics. Built in spreadsheets, it gets rebuilt every quarter and the definitions drift.

How to set up field force effectiveness reporting

Agree definitions first

Write down what counts as a call, a target, reach, frequency and a new-to-brand prescription, and get brand, sales operations and the regions to sign the same page.

Build the prescriber master

Match HCPs across CRM, prescription data and marketing systems on NPI, and resolve duplicates before any metric is calculated.

Date the target list and roster

Store target lists, segments and territory assignments with effective dates so history can be recalculated fairly.

Automate the weekly load

Load CRM and prescription deliveries on schedule with checks for late, duplicate or incomplete files, so the scorecard refreshes itself.

Publish a territory diagnostic

One view per territory with the metric chain from call-on-target to outcome lift, drillable to the HCP list a manager can act on.

Test before you scale a change

When you retarget, change frequency or add a channel, compare against a matched group so you know whether the change worked.

Build, buy or outsource?

CRM analytics

CRM vendors ship activity dashboards and, increasingly, AI features. They are quick to switch on and good for call activity, but they rarely hold prescriber-level demand data or a dated target history, so outcome measures sit elsewhere.

Analytics platform

Specialist platforms promise FFE dashboards and AI insights out of the box. Most publish no prices, and they still need your prescriber master and clean data feeds before the dashboards mean anything.

Build on your warehouse

Build the commercial data model and scorecards in Snowflake, Databricks, Fabric or BigQuery with Power BI or Tableau on top. Slower to start, but you own the definitions and the same model feeds incentives, sizing and launch tracking.

Outsourced build

A consultancy builds the model, pipelines and scorecards in your tenant and hands them over or runs them. Suits companies without a commercial data team, as long as you own the code, the data and the definitions at the end.

Common field force effectiveness mistakes

  • Scoring activity, not targeting

    Calls per day rewards whoever is easiest to see. Pair every activity metric with call-on-target and segment frequency.

  • No history on the target list

    Recalculating last quarter against today's targets makes some reps look worse and others better than they were.

  • Vacancies counted as failures

    A territory with no rep for three months should be flagged as vacant, not ranked last.

  • Attribution by assumption

    Reps called on prescribers who were already growing will look effective. Use a matched comparison group before you credit the field.

  • One national average

    Averages hide the territories where the chain breaks. Diagnose at territory and HCP level, then roll up.

  • Fixing headcount first

    Adding reps to a territory with a poor call-on-target rate buys more off-list calls. Fix targeting, then revisit sizing.

When field force effectiveness analytics is not worth funding yet

Your field force is a handful of key account managers covering a few dozen treatment centres, where a shared account plan is enough
You do not license prescriber-level demand data, so outcome metrics cannot be built and activity metrics alone would mislead
The target list and segmentation are about to be rebuilt for a launch or new indication; measure against the new list, not the old one
Reps are not logging calls consistently in CRM, in which case the first fix is CRM adoption, not analytics
The business is deciding whether to keep a field force at all, which is a sizing and economics question first

Where Greenwolf fits

Field force effectiveness sits on the same foundation as most pharma commercial work: a clean prescriber master, dated targeting and alignment, automated CRM and prescription loads, and dashboards that brand, sales operations and managers read the same way. Greenwolf's founder came up through pharma commercial operations consulting at ZS, and our pharma commercial analytics consulting team builds that foundation in your own environment, then adds the territory diagnostic, call planning support and outcome testing on top.

If the diagnostic points to a structural problem, the next steps are usually sales force sizing or territory alignment and call planning. If you are weighing an outside team against hiring, our view is in pharma commercial analytics outsourcing. For the wider picture of our pharma practice, see specialty pharmacy analytics.

Questions about field force effectiveness in pharma

What is field force effectiveness in pharma?
It is how well a pharma sales force turns its time and cost into commercial results. In practice it is measured as a chain: whether reps call on the right prescribers, how often, how well that activity is coordinated with other channels, and whether new-to-brand prescriptions rise as a result.
What KPIs measure field force effectiveness?
The core set is call-on-target rate, reach, frequency by segment, call plan attainment, access rate, channel coordination, outcome lift against a matched group and cost per outcome. Activity counts such as calls per day are useful only alongside those.
What is the difference between sales force effectiveness and field force effectiveness?
The terms are used almost interchangeably. Sales force effectiveness is the older label and often includes sizing, structure and incentives; field force effectiveness is increasingly used to cover medical science liaisons and key account managers as well as sales reps.
How do you improve field force effectiveness?
Find where the metric chain breaks, territory by territory. Most improvements come from tighter targeting, moving calls from off-list prescribers to under-covered high-potential ones, and coordinating rep visits with digital follow-up, before any change in headcount.
What data do you need for field force analytics?
A prescriber master keyed on NPI, a dated target list and segmentation, a dated territory roster, CRM activity from Veeva or Salesforce, and prescriber-level prescription data. Specialty pharmacy data is needed for limited-distribution brands.
Can a small pharma company do field force effectiveness without a big platform?
Yes. With 20 to 80 reps, a commercial data model in your existing warehouse and a Power BI or Tableau scorecard is often enough. The effort goes into the prescriber master and definitions, not the software.
How does AI help field force effectiveness?
AI can rank prescribers, suggest next best actions and summarise call notes. Veeva's Q1 2026 Agentic Commercial Trends Report found that 65% of agentic call reports revealed actionable treatment barriers. Any model should still be tested against a holdout group before the field relies on it.

Want to see where your field force chain breaks?

Tell us how many reps you have, which CRM you run and what prescription data you license. We will show you what a territory diagnostic would look like on your data and what it takes to automate it.

Contact us

Reviewed by Team Greenwolf Tech Labs ยท

Part of our Pharma Commercial and Patient Analytics hub. Start with our specialty pharmacy analytics.

Talk to us

Is this a problem you are living with?

If any of the above sounds like your week, tell us which part. We will come back with what it would take to fix it.

  • A reply from a consultant, not a sales sequence
  • Usually within one working day
  • No obligation, and nothing to sit through

We reply from [email protected], usually within one working day. We do not add you to a mailing list.